This book takes you on a journey into the future of ethical research, offering a collection of expert commentaries on the latest revision of the World Medical Association's cornerstone document, exploring its profound implications for global health ethics and proposing a path for its improvement. The book consists of three main parts, each focusing on key issues of human rights, integrity and inclusivity, with each chapter enriching the discourse on ethical research practices. The first part provides contextual perspectives on the implementation of research ethics, particularly in the Global South and Asia, by gathering revealing insights from different corners of the globe. This is followed by forward-looking perspectives for international ethical principles, and the final part describes not only the transformation of the Declaration, but also pushes it forward as a dynamic framework for ethical innovation to achieve access to health for all.
The 2024 Declaration of Helsinki could be marked by global discussions to be consolidated towards the highest ethical standards based on the experience of the COVID-19 pandemic, trends to promote the involvement of patients, participants and public in research projects, and the growing attention to data-driven research. Each chapter demonstrates the pathway to Ethical Innovation for Global Health.
The 2024 Declaration of Helsinki: Global Efforts Towards Highest Ethical Standards is essential reading for scientists, practitioners, and policymakers committed to the highest standards of ethical conduct in research. Members of research ethics committees, pharmaceutical company employees, medical students, patients and members of the public involved in human research will also find this volume useful.
Part 1 Research Ethics Perspectives from the Global South and Asia.-
Chapter 1 Bioethics in Brazil to Overcome Pandemics: Striving for Highest
Ethical Standards to Prevent Exploitation and to Achieve Health For All - A
Case Study of the AIDS and COVID-19 Pandemics.
Chapter 2 Ubuntu Principles:
Solidarity to Include Vulnerable Communities For Equitable Access.
Chapter 3
Strengthening Ethical Safeguards Protecting Vulnerable Populations in Egypt:
Role of Research Ethics Committee.
Chapter 4 The DoH, the DoT, and the Duty
to Participate in Data Research: A Case Reflection from Taiwan.
Chapter 5
Ethical, Legal and Social Issues of Biobanks Including Brain Banks:
Experiences in South Korea, Taiwan and Japan and Future Perspectives for
Global Principles.
Chapter 6 From COVID-19 to Global Standards: Redefining
Korean Bioethics and Research Ethics.
Chapter 7 Scientific Misconduct and
the Waste of Research Funding: Can Existing Ethical Principles and Legal
Frameworks be Sufficient to Prevent Intentional Violations?.
Chapter 8 From
Professional Freedom to Professional Autonomy: Ethical Principles for the Use
of Unproven Interventions.- Part 2 Historical and International
Perspectives.
Chapter 9 Bridging between the CIOMS and the WMA: Common
Ground, Similarities, Differences, and Next Steps.
Chapter 10 Justice and
Equity of Placebo-Controlled Trials: What Has Changed?.
Chapter 11
Post-trial Access as a Fundamental Right to Health: What Has Changed in the
Implementation Principles?.
Chapter 12 Universities as Guardians of Ethics
and Equity in Medical Research: Protecting the Rights of Vulnerable
Populations, Ensuring Post-Trial Access, and Advancing Transparency in
Clinical Trials.
Chapter 13 Patient Public Declaration of Research Ethics:
Opinions and Proposals from Patients and the Public on Research Ethics.- Part
3 Alternative Frameworks of Innovation.
Chapter 14 Medicines Development
for Global Health: The Evolution of IFAPPs Ethical Framework in the
Ecosystem of the Life Sciences in a New World Order for Health.
Chapter 15
Ethical Principles for the Sustainable Development of Drugs for Neglected
Tropical Diseases in Neglected Populations: Facilitating Meaningful
Participation of Vulnerable People and Communities.
Chapter 16 Reformation
of Global Research Ethics Principles from the Perspective of Patient Public
Involvement.
Chapter 17 Global Efforts Towards the Highest Ethical
Standards: Horizon For the Future.
Prof. Kurihara, Kanagawa Dental University, also engaged in Vice-chair of Certified Review Board of the National Institute for Quantum Science and Technology, Editor-in-Chief of a Journal Clinical Evaluation, Ethics Woking Group of International Federation of Pharmaceutical Physicians and Pharmaceutical Medicine, Task Group of the International Commission on Radiological Protection.
Prof. Greco, Professor Emeritus, School of Medicine, Federal University of Minas Gerais, is specialized in infectious diseases and clinical immunology and is involved in several international activities, e.g., Past President of the Brazilian Society of Bioethics, member of UNESCO International Bioethics Committee, CIOMS Ethical Guidelines for Health-Related Research, as well as WHO, UNAIDS, UNICEF, WMA and the United States Presidential Commission for the Study of Bioethical Issues.
Prof. Dhai is the Founder and Past Director of the Steve Biko Center for Bioethics at the Wits Faculty of Health Sciences, Professor of Bioethics, School of Clinical Medicine, University of the Witwatersrand, Specialist Ethicist at South African Medical Research Council, Past Chairperson of the UNESCO International Bioethics Committee, Vice Chairperson of the South African Medical Association
